Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
- PMID: 25245211
- PMCID: PMC4195405
- DOI: 10.1016/j.ijantimicag.2014.06.003
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
Keywords: Burkholderia; Cambodia; Co-trimoxazole; Laos; Melioidosis; Pseudomallei; Resistance; Susceptibility; Treatment.
Figures
References
-
- Chetchotisakd P., Chierakul W., Chaowagul W., Anunnatsiri S., Phimda K., Mootsikapun P. Trimethoprim–sulfamethoxazole versus trimethoprim–sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807–814. - PMC - PubMed
-
- Piliouras P., Ulett G.C., Ashhurst-Smith C., Hirst R.G., Norton R.E. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Int J Antimicrob Agents. 2002;19:427–429. - PubMed
-
- Wuthiekanun V., Cheng A.C., Chierakul W., Amornchai P., Limmathurotsakul D., Chaowagul W. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029–1031. - PubMed
-
- Clinical and Laboratory Standards Institute . CLSI; Wayne, PA: 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline—second edition. Document M45-A2.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
